Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pestronk

Showing results (131-140 of 151) with videos related to

Pageof 16
Sort By:
Annals of Neurology|February 1, 1994
Trial of immunosuppression in amyotrophic lateral sclerosis using total lymphoid irradiationD B Drachman, V Chaudhry, D Cornblath, et al.
Annals of the New York Academy of Sciences|June 21, 1993
A novel therapy for myasthenia gravis by reducing the endocytosis of acetylcholine receptorsR W Kuncl, I Wittstein, R N Adams, et al.
Annals of Neurology|July 1, 1990
Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosisJ D Rothstein, G Tsai, R W Kuncl, et al.
Annals of Surgery|October 16, 1999
Results of transcervical thymectomy for myasthenia gravis in 100 consecutive patientsR F Calhoun, J H Ritter, T J Guthrie, et al.
Neurology|January 1, 1997
Serum IgM monoclonal autoantibody binding to the 301 to 314 amino acid epitope of beta-tubulin: clinical association with slowly progressive demyelinating polyneuropathyA M Connolly, A Pestronk, S Mehta, et al.
Neurology|March 29, 2006
Frequency of spinal arteriovenous malformations in patients with unexplained myelopathyR G Strom, C P Derdeyn, C J Moran, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 20, 2006
Peripheral neuropathies in Waldenström's macroglobulinaemiaT Levine, A Pestronk, J Florence, et al.
Archives of Neurology|June 1, 1991
A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophyG M Fenichel, J R Mendell, R T Moxley, et al.
Neurology|December 1, 1991
Long-term benefit from prednisone therapy in Duchenne muscular dystrophyG M Fenichel, J M Florence, A Pestronk, et al.
Annals of Neurology|March 1, 1990
Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodiesA Pestronk, V Chaudhry, E L Feldman, et al.
Pageof 16

Showing results (131-140 of 151) with videos related to

Sort By:
Pageof 16
Annals of Neurology|February 1, 1994
Trial of immunosuppression in amyotrophic lateral sclerosis using total lymphoid irradiationD B Drachman, V Chaudhry, D Cornblath, et al.
Annals of the New York Academy of Sciences|June 21, 1993
A novel therapy for myasthenia gravis by reducing the endocytosis of acetylcholine receptorsR W Kuncl, I Wittstein, R N Adams, et al.
Annals of Neurology|July 1, 1990
Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosisJ D Rothstein, G Tsai, R W Kuncl, et al.
Annals of Surgery|October 16, 1999
Results of transcervical thymectomy for myasthenia gravis in 100 consecutive patientsR F Calhoun, J H Ritter, T J Guthrie, et al.
Neurology|January 1, 1997
Serum IgM monoclonal autoantibody binding to the 301 to 314 amino acid epitope of beta-tubulin: clinical association with slowly progressive demyelinating polyneuropathyA M Connolly, A Pestronk, S Mehta, et al.
Neurology|March 29, 2006
Frequency of spinal arteriovenous malformations in patients with unexplained myelopathyR G Strom, C P Derdeyn, C J Moran, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 20, 2006
Peripheral neuropathies in Waldenström's macroglobulinaemiaT Levine, A Pestronk, J Florence, et al.
Archives of Neurology|June 1, 1991
A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophyG M Fenichel, J R Mendell, R T Moxley, et al.
Neurology|December 1, 1991
Long-term benefit from prednisone therapy in Duchenne muscular dystrophyG M Fenichel, J M Florence, A Pestronk, et al.
Annals of Neurology|March 1, 1990
Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodiesA Pestronk, V Chaudhry, E L Feldman, et al.
Pageof 16